Novel Neuromodulatory Intervention in the Rehabilitation of Pediatric Hemiparesis

小儿偏瘫康复中的新型神经调节干预

基本信息

  • 批准号:
    9293908
  • 负责人:
  • 金额:
    $ 13.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-26 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This project is designed to train to independence Bernadette Gillick, PhD, MSPT, PT as a rehabilitation scientist and to advance rehabilitation research in children with neurologic deficits. Dr. Gillick is a developing rehabilitation scientist with over two decades of clinical experience; with research interest both in the reorganization of the developing brain after neurologic insult or injury, and in the influence of electrophysiologic and behavioral interventions on neurorecovery. Dr. Gillick's career development objectives include expanding her knowledge of running clinical trials, mastering techniques to investigate brain reorganization and creating novel interventions designed to enhance functional motor recovery. Since last submission, Dr. Gillick has reassembled a comprehensive team of mentors and a research advisory committee to direct and guide her training. The training plan includes formal meetings with mentors, didactic training with a Certificate in Clinical Research, national meeting presentations, preparation of grant applications and manuscripts. The research project takes Dr. Gillick's work in a direction not yet studied-the use of a novel form of non-invasive brain stimulation in pediatric rehabilitation. Through her prior experience, she has learned that electrophysiologic and behavioral interventions can have a beneficial synergistic effect. She has also recently completed a safety pilot in the use of a novel form of non-invasive brain stimulation. Based on these promising findings Dr. Gillick proposes to combine interventions that, with a more thorough understanding of their effects, can conveniently reach the clinical setting and will cost less. The integration of this novel rehabilitation approach may lead to improved motor function for individuals throughout their lifetimes. The advanced support provided by the K01 career development training and research of Dr. Gillick will contribute to the NIH by producing an independent scientist able to conduct clinically relevant and translational research in pediatric neurorecovery.
描述(由申请人提供):该项目旨在培养独立伯纳黛特吉利克博士,MSPT,PT作为康复科学家,并推进神经功能缺损儿童的康复研究。吉利克博士是一位发展中的康复科学家 具有二十多年的临床经验;研究兴趣包括神经损伤或损伤后发育中大脑的重组,以及电生理和行为干预对神经恢复的影响。Gillick博士的职业发展目标包括扩大她在开展临床试验方面的知识,掌握研究大脑重组的技术,以及创造旨在增强功能性运动恢复的新型干预措施。自上次提交以来,Gillick博士重新组建了一个全面的导师团队和一个研究咨询委员会来指导和指导她的培训。培训计划包括与导师的正式会议,临床研究证书的教学培训,国家会议演讲,赠款申请和手稿的准备。该研究项目将吉利克博士的工作引向了一个尚未研究的方向--在儿科康复中使用一种新型的非侵入性脑刺激。通过她以前的经验,她已经了解到,电生理和行为干预可以有一个有益的协同效应。她最近还完成了一项使用新型非侵入性脑刺激的安全试验。基于这些有希望的发现,Gillick博士建议将联合收割机干预措施结合起来,通过更彻底地了解其效果,可以方便地达到临床环境并且成本更低。这种新型康复方法的整合可能会改善运动功能个人的一生。Gillick博士的K 01职业发展培训和研究提供的先进支持将通过培养一名能够在儿科神经恢复方面进行临床相关和转化研究的独立科学家,为NIH做出贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bernadette Therese Gillick其他文献

Bernadette Therese Gillick的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bernadette Therese Gillick', 18)}}的其他基金

Perinatal Stroke: Longitudinal Assessment of Infant Brain Organization and Recovery through Neuroexcitability, Neuroimaging and Motor Development
围产期中风:通过神经兴奋性、神经影像学和运动发育对婴儿大脑组织和恢复进行纵向评估
  • 批准号:
    10260391
  • 财政年份:
    2021
  • 资助金额:
    $ 13.08万
  • 项目类别:
Perinatal Stroke: Longitudinal Assessment of Infant Brain Organization and Recovery through Neuroexcitability, Neuroimaging and Motor Development
围产期中风:通过神经兴奋性、神经影像学和运动发育对婴儿大脑组织和恢复进行纵向评估
  • 批准号:
    10340498
  • 财政年份:
    2021
  • 资助金额:
    $ 13.08万
  • 项目类别:
Perinatal Stroke: Longitudinal Assessment of Infant Brain Organization and Recovery through Neuroexcitability, Neuroimaging and Motor Development
围产期中风:通过神经兴奋性、神经影像学和运动发育对婴儿大脑组织和恢复进行纵向评估
  • 批准号:
    10643800
  • 财政年份:
    2021
  • 资助金额:
    $ 13.08万
  • 项目类别:
Novel Neuromodulatory Intervention in the Rehabilitation of Pediatric Hemiparesis
小儿偏瘫康复中的新型神经调节干预
  • 批准号:
    8820522
  • 财政年份:
    2014
  • 资助金额:
    $ 13.08万
  • 项目类别:
Novel Neuromodulatory Intervention in the Rehabilitation of Pediatric Hemiparesis
小儿偏瘫康复中的新型神经调节干预
  • 批准号:
    9094278
  • 财政年份:
    2014
  • 资助金额:
    $ 13.08万
  • 项目类别:
Novel Neuromodulatory Intervention in the Rehabilitation of Pediatric Hemiparesis
小儿偏瘫康复中的新型神经调节干预
  • 批准号:
    9531420
  • 财政年份:
    2014
  • 资助金额:
    $ 13.08万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 13.08万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 13.08万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 13.08万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 13.08万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 13.08万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 13.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了